PLAY PODCASTS
Hepatitis Delta a Major Global Problem: Screening, Diagnosis, and Treatment in 2022 – Physician Discussion #1
Episode 154

Hepatitis Delta a Major Global Problem: Screening, Diagnosis, and Treatment in 2022 – Physician Discussion #1

In this podcast, CCO’s expert faculty discusses HDV epidemiology beyond the United States, the features of HDV/HBV pathology, insights into screening and diagnostic approaches, key aspects of disease staging, new treatment options, and important remaining clinical questions regarding optimal management of HDV.

Decera Clinical Education Infectious Disease Podcast · Heiner Wedemeyer MD

March 30, 202224m 55s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode,  Heiner Wedemeyer, MD, discusses HDV epidemiology beyond the United States, the features of HDV/HBV pathology, insights into screening and diagnostic approaches, key aspects of disease staging, new treatment options, and important remaining clinical questions regarding optimal management of HDV.

Presenter:

Heiner Wedemeyer, MD
Professor and Chairman
Department of Gastroenterology, Hepatology and Endocrinology
Hannover Medical School
Hannover, Germany

Content based on an online CME program supported by independent educational grants from AbbVie and Gilead Sciences, Inc. and developed in collaboration with the American Liver Foundation. 

Link to full program:
https://bit.ly/3KmJvZt


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

hdv prognosishepatitis delta virushepatitis delta virus treatmenthdv genotypehepatitis delta virus liver staginghdv treatment durationhdv peginterferonhepatitis delta virus epidemiologybulevirtidehdv antibodyhepatitis delta virus genotypehdv liver staginghepatitis delta virus peginterferonhepatitis delta virus treatment durationhdv screeninghdvhbv hdvhdv diagnosishepatitis delta virus diagnosishepatitis delta virus screeninghdv treatmenthdv epidemiologyhdv rna testhepatitis delta virus prognosis